Live bacterial biotherapeutics in the clinic

An engineered probiotic designed to treat a metabolic disease enters clinical trials.

Saved in:

Bibliographic Details
Published in:	Nature biotechnology Vol. 36; no. 9; pp. 816 - 818
Main Authors:	Bermúdez-Humarán, Luis G, Langella, Philippe
Format:	Journal Article
Language:	English
Published:	New York Nature Publishing Group US 01-09-2018 Nature Publishing Group
Subjects:	631/154/436 631/326/2522 692/699/317 Agriculture Bacteria Bias Bioinformatics Biomarkers Biomedical Engineering/Biotechnology Biomedicine Biotechnology Clinical trials E coli Enzymes Escherichia coli Gene expression Genes Genetic engineering Genomes Genomics Haplotypes Health aspects Hydroxylases Life Sciences Metabolic disorders Methods Microbial colonies news-and-views Phenylalanine Phenylketonuria Population Probiotics Therapeutics
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	An engineered probiotic designed to treat a metabolic disease enters clinical trials.
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Commentary-1
ISSN:	1087-0156 1546-1696
DOI:	10.1038/nbt.4248